Regadenoson 72611-0874-10

Package NDC

72611-0874-10

Manufacturer: Almaject, Inc.
Dosage Form: Injection, Solution
Route: Intravenous
Product Type: Human Prescription Drug
Marketing Start: July 3, 2023
Listing Expires: December 31, 2026
Application: ANDA207320

Need to source Regadenoson? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Regadenoson	.08 mg/mL

Drug Class

Adenosine Receptor Agonist [EPC]Adenosine Receptor Agonists [MoA]Pharmacologic Cardiac Stress Test Agent [EPC]

Selected Package

72611-0874-10Selected

10 VIAL, SINGLE-DOSE in 1 CARTON (72611-874-10) / 5 mL in 1 VIAL, SINGLE-DOSE (72611-874-01)